Switch theme
Sign up to access all valuation multiples
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world’s first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
2023
137
LTM Revenue $31.2M
LTM EBITDA -$40.4M
$37.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Allurion has a last 12-month revenue of $31.2M and a last 12-month EBITDA of -$40.4M.
In the most recent fiscal year, Allurion achieved revenue of $32.1M and an EBITDA of -$22.2M.
Allurion expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Allurion valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $53.5M | $32.1M | XXX | XXX | XXX |
| Gross Profit | $50.7M | $41.5M | XXX | XXX | XXX |
| Gross Margin | 95% | 129% | XXX | XXX | XXX |
| EBITDA | -$69.0M | -$22.2M | XXX | XXX | XXX |
| EBITDA Margin | -129% | -69% | XXX | XXX | XXX |
| Net Profit | -$37.7M | -$80.6M | XXX | XXX | XXX |
| Net Margin | -71% | -251% | XXX | XXX | XXX |
| Net Debt | $48.8M | $0.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Allurion's stock price is $3.
Allurion has current market cap of $15.3M, and EV of $37.8M.
See Allurion trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $37.8M | $15.3M | XXX | XXX | XXX | XXX | $-9.65 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Allurion has market cap of $15.3M and EV of $37.8M.
Allurion's trades at 1.2x LTM EV/Revenue multiple, and -0.9x LTM EBITDA.
Analysts estimate Allurion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Allurion and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $37.8M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | -1.7x | XXX | XXX | XXX |
| P/E | -0.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -0.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAllurion's NTM/LTM revenue growth is 3%
Allurion's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.5M for the same period.
Over next 12 months, Allurion's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Allurion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Allurion and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -40% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -69% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -68% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -66% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.5M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 81% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 88% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 54% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 223% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Allurion acquired XXX companies to date.
Last acquisition by Allurion was XXXXXXXX, XXXXX XXXXX XXXXXX . Allurion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Allurion founded? | Allurion was founded in 2023. |
| Where is Allurion headquartered? | Allurion is headquartered in United States of America. |
| How many employees does Allurion have? | As of today, Allurion has 137 employees. |
| Who is the CEO of Allurion? | Allurion's CEO is Dr. Shantanu Gaur, M.D.. |
| Is Allurion publicy listed? | Yes, Allurion is a public company listed on NYS. |
| What is the stock symbol of Allurion? | Allurion trades under ALUR ticker. |
| When did Allurion go public? | Allurion went public in 2023. |
| Who are competitors of Allurion? | Similar companies to Allurion include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Allurion? | Allurion's current market cap is $15.3M |
| What is the current revenue of Allurion? | Allurion's last 12-month revenue is $31.2M. |
| What is the current EBITDA of Allurion? | Allurion's last 12-month EBITDA is -$40.4M. |
| What is the current EV/Revenue multiple of Allurion? | Current revenue multiple of Allurion is 1.2x. |
| What is the current EV/EBITDA multiple of Allurion? | Current EBITDA multiple of Allurion is -0.9x. |
| What is the current revenue growth of Allurion? | Allurion revenue growth between 2023 and 2024 was -40%. |
| Is Allurion profitable? | Yes, Allurion is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
